EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative APTM against Mycoplasma gallisepticum

Weicong Yang, Huanzhong Ding, Xiaona Ma, Taiming Lv, Luoju Wang

Poultry Science · 2026

DOI: 10.1016/j.psj.2026.106560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Poultry Science, 2026. Verfasst von Weicong Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Veterinary Drug Residue Standard Laboratory, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China; National…. Hauptthemen laut MEDLINE: Mycoplasma gallisepticum, Chickens, Poultry Diseases, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycoplasma gallisepticum (MG) is a primary avian pathogen that causes chronic respiratory disease, leading to significant economic losses in the poultry industry. This study aimed to investigate the pharmacokinetic/pharmacodynamic (PK/PD) relationship of a novel pleuromutilin derivative, 14-O-[(4-amino-6-hydroxy-pyrimidine-2-yl) thioacetyl] mutilin (APTM), against MG in a chicken infection model to provide a basis for a rational dosage regimen. The in vitro activity of APTM against MG strain S6 was assessed by determining the minimum inhibitory concentration (MIC) and time-kill kinetics. An intratracheal MG infection model was established in chickens. The pharmacokinetic profile was evaluated after single oral administrations of APTM at 5, 15, and 40 mg/kg. The pharmacodynamic efficacy was determined by quantifying the bacterial reduction in the lungs after three consecutive days of oral treatment with doses ranging from 0 to 40 mg/kg. The PK/PD data were integrated and analyzed using an inhibitory sigmoid Emax model. The MIC of APTM against MG S6 was 0.03125 µg/mL, and in vitro time-kill assays demonstrated concentration-dependent bactericidal activity. In chickens, APTM was rapidly absorbed (Tmax: 0.25-0.5 h), with both Cmax and AUC0-24h exhibiting excellent dose proportionality (R² > 0.99) over the tested range. In the efficacy study, APTM produced a dose-dependent reduction in lung bacterial load, with a maximum mean reduction of 2.80 log10CFU/mL observed at the 40 mg/kg dose, indicating a bactericidal effect. The PK/PD indices, AUC0-24h/MIC and Cmax/MIC, were both highly correlated with the in vivo antimicrobial effect (R² = 0.9424 and 0.9428, respectively). To achieve a 2-log10CFU/mL reduction in bacterial load, the target AUC0-24h/MIC value was determined to be 492.75, which corresponds to a calculated daily oral dose of 22 mg/kg. These findings demonstrate the potent efficacy of APTM against MG and provide a quantitative scientific foundation for its therapeutic use in poultry. Specifically, a daily oral dose of 22 mg/kg was identified as the breakpoint for a bactericidal effect (2-log10 reduction), suggesting APTM is a potent candidate for controlling MG infections in poultry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma gallisepticumChickensPoultry DiseasesAnti-Bacterial AgentsDiterpenesMycoplasma InfectionsAnimalsPleuromutilinsMicrobial Sensitivity TestsPolycyclic CompoundsDose-Response Relationship, Drug

Stichwörter der Autor:innen

APTMChickenMycoplasma gallisepticumPharmacokinetics/pharmacodynamics (PK/PD)Pleuromutilin

Substanzen

Anti-Bacterial AgentsDiterpenesPleuromutilinsPolycyclic Compounds

Autor:innen und Institutionen

  • National Veterinary Drug Residue Standard Laboratory, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China; National Veterinary Drug Safety Evaluation (Environmental Assessment) Laborato…
  • Shandong Qilu-Kingphar Pharmaceutical Com. Ltd., Pingyin County, Jinan, China.
  • Shandong Qilu-Kingphar Pharmaceutical Com. Ltd., Pingyin County, Jinan, China. Electronic address: luoju.wang@qilu-pharma.com.

Zitieren

APA

Yang, W., Ding, H., Ma, X., Lv, T., & Wang, L. (2026). Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative APTM against Mycoplasma gallisepticum. Poultry Science. https://doi.org/10.1016/j.psj.2026.106560

Vancouver

Yang W, Ding H, Ma X, Lv T, Wang L. Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative APTM against Mycoplasma gallisepticum. Poultry Science. 2026. doi:10.1016/j.psj.2026.106560

BibTeX
@article{Yang2026,
  author = {Yang, Weicong and Ding, Huanzhong and Ma, Xiaona and Lv, Taiming and Wang, Luoju},
  title = {Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative APTM against Mycoplasma gallisepticum},
  journal = {Poultry Science},
  year = {2026},
  doi = {10.1016/j.psj.2026.106560}
}
Kostenlos starten →